ATHIRA PHARMA INC (ATHA)
US04746L1044 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -117.67M | -95.64M | -54.85M | -19.96M | -5.16M | |||
| Depreciation Amortization | 969.00K | 850.00K | 480.00K | N/A | N/A | |||
| Change In Working Capital | 6.53M | 11.94M | 6.16M | -6.45M | 680.00K | |||
| Other non cash items | 9.42M | 10.39M | 5.12M | 2.29M | 770.00K | |||
| OPERATING CASH FLOW | -100.75M | -72.47M | -43.10M | -24.11M | -3.71M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -304.00K | -1.14M | -1.57M | -2.32M | N/A | |||
| Other Investing Activity | 95.39M | 58.81M | -2.51M | -207.75M | 1.51M | |||
| INVESTING CASH FLOW | 95.09M | 57.66M | -4.08M | -210.07M | 1.51M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 1.66M | 880.00K | |||
| Stock Issued/Repurchased | 493.00K | 650.00K | 97.09M | 291.09M | 70.00K | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | -10.00K | |||
| FINANCING CASH FLOW | 493.00K | 650.00K | 97.09M | 292.75M | 950.00K | |||
| CHANGE IN CASH | -5.17M | -14.16M | 49.91M | 58.57M | -1.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -100.75M | -72.47M | -43.10M | -24.11M | -3.71M | |||
| Capital Expenditure | -304.00K | -1.14M | -1.57M | -2.32M | N/A | |||
| FREE CASH FLOW | -101.06M | -73.61M | -44.67M | -26.43M | -3.71M | |||
All data in USD